The global proteomics market grew at a CAGR of around 15% during 2014-2019.
Proteomics refers to the study of proteomes, their structure and physiological functions on a large-scale. In 1994, Mark Wilkins first coined the term proteome for the proteins that are translated from genome, to denote the whole set of proteins synthesized within a living organism. It encompasses the modifications and alterations that take place in the existing protein when it is exposed to varying conditions. Proteomics applies various technologies for the quantification and identification of proteins, along with the detection of diagnostic markers, understanding of pathogens in cells and interpretation of protein pathways in different diseases. It also evaluates the rate of protein production and the interaction patterns of proteins due to which it finds extensive applicability in drug discovery and the development of personalized medications.
The growing preference for personalized drugs, along with increasing research and development in drug discovery and biotechnology, is the key factor driving the growth of the market. Proteomic systems reduce the time, cost and resources needed for the chemical synthesis and biological testing of drugs and simplify the process of drug discovery. Furthermore, opportunities related to biomarker identification and mass spectrometry-based proteomics are favoring the market growth further. Additionally, the market is driven by increasing technological penetration in the comprehensive analysis of protein techniques. These techniques include Electrospray Ionization-Liquid Chromatography-Mass Spectrometry (ESI-LC-MS), surface plasma resonance, microarray, protein fractionation systems and X-ray crystallography. These advancements enable a thorough quantitative and qualitative analysis of proteins and identification of cancer therapies and treatments. Other factors, such as favorable government policies for extensive research and development (R&D) are also augmenting the growth of the market. Looking forward, the analyst expects the market to continue its strong growth during the next five years.
Breakup by Analysis Type: Structural Proteomics Functional Proteomics Protein Expression Proteomics
Breakup by Component Type: Core Proteomics Services Bioinformatics Software and Related Services
Breakup by Technology: Spectroscopy Chromatography Electrophoresis Protein Microarrays X-Ray Crystallography Surface Plasmon Resonance Others
Breakup by Application: Protein Expression Profiling Proteome Mining Post-translational Modifications
Breakup by End-User: Clinical Diagnostic Laboratories Research Organizations (Drug Discovery) Others
Breakup by Region: North America United States Canada Asia Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa
Competitive Landscape: The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Bruker Corporation, Creative Proteomics, Danaher Corporation, GE Healthcare Inc., Horiba Ltd., Luminex Corporation, Merck Group, Perkinelmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.
Key Questions Answered in This Report: How has the global proteomics market performed so far and how will it perform in the coming years? What are the key regional markets? What is the breakup of the market based on the analysis type? What is the breakup of the market based on the component type? What is the breakup of the market based on the technology? What is the breakup of the market based on the application? What is the breakup of the market based on the services and software? What is the breakup of the market based on the application? What is the breakup of the market based on the end-user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global proteomics market and who are the key players? What is the degree of competition in the industry?
Our reports have been used by over 10K customers, including:
Proteomics Market Research Report by Technology (Chromatography, Electrophoresis, Protein Microarrays, Spectroscopy, and X-Ray Crystallography), by Offerings (Bioinformatics Software and Services and Core Proteomics Services), by Reagent, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market...
The global transient protein expression market is expected to reach US$ 983.10 million by 2027 from US$ 660.00 million in 2019. The market is estimated to grow at a CAGR of 5.3% from 2020 to 2027. Increasing applications of protein expression and growing adoption of precision medicines are expected to boost the market growth over the years....
The Global Proteomics Partnering Terms and Agreements 2010 to 2020 report provides an understanding and access to the Proteomics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Proteomics partnering deals Disclosed headlines, upfronts, milestones and royalties by...
289 pages •
By Global Industry Analysts
• Sep 2020
Global Genomics and Proteomics Reagents, Research Kits and Analytical Instruments Market to Reach $72.5 Billion by 2027 Amid the COVID-19 crisis, the global market for Genomics and Proteomics Reagents, Research Kits and Analytical Instruments estimated at US$35.4 Billion in the year 2020, is projected to reach a revised size of US$72.5...
Protein Detection and Quantification Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Protein Detection and Quantification market including the...
Transcriptomics Technologies Market Research Report by Technology (Gene Regulation Technologies, Microarray, Next Generation Sequencing, and PCR), by Application (Bioinformatics, Clinical Diagnostics, Comparative Transcriptomics, and Drug Discovery & Research), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market...
Specific Proteins Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Specific Proteins Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Specific Proteins Tests pipeline products with comparative analysis of the...
Plant Genomics Market Research Report by Objective (DNA Extraction & Purification, DNA/Rna Sequencing, GMO-Trait Purity Testing, Gene Expression Profiling, and Genotyping), by Type (Genetic Engineering and Molecular Engineering), by Trait, by Crops - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The...
Global DNA Sequencing market is expected to witness a CAGR of 18.9% during the forecast period. Certain factors that are driving the market growth include the rise in technological advancements in DNA sequencing, increasing application in clinical diagnosis and drug discovery, and growing investment in R&D. The technological advancements...
The global spatial genomics and transcriptomics market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period. Market growth is largely driven by the increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups, expanding applications...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.